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CHAPTER SEVENTEEN
 
Division of Endocrine and
 
Metabolic Diseases
 
JOSEPH J. Rupp, M.D. 
"We may) of course) strike a balance 
between what a living organism takes in 
as nourishment and what it gives out in 
excretions. ... That could be like trying 
to tell what happens inside a house by 
watching what goes in by the door and 
what comes out by the chimney.)) 
-CLAUDE BERNARD (1813-1878) 
T HE College was 2+ years. old when, in 18+8, laid the foundations of the science of metabolism. A. A. Berthold,[ of Gbttmgen, reported Bernard's successor, Charles Edouard Brown­that transplantation of the testis restored Seguard (1817-189+), continued the physiological 
secondary sex characteristics in castrated roosters. approach and made significant observations 
This observation established endocrine physiology concerning the nervous system. Best known as a 
as a science. During this same period Claude neurologist, Brown-Seguard is also remembered 
Bernard was studying the hepatic metabolism of because of the report of his marked increase in 
sugars and in 1855 first used the phrase "internal vigor and potency in 18893 following the self­
secretions."2 Bernard's experimental observations injection of an emulsion of bull testes, one of the 
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early observations of therapeutic trials and the 
beginning of a long era of the use of cell extracts 
in an attempt at rejuvenation. 
A amous Last de Medici 
at Jefferson 
Modern endocrinology had its birth in Europe, 
especially in France, where the "Father of 
American Endocrinology" trained under Brown­
Sequard. Charles Eucharist de Medici Sajous 
(Figure 17-1) was born at sea and received his eady 
education in France. He was a descendant of the 
Florentine de Medicis and the royal house of 
France. His father died when he was two years 
old, and his mother remarried; Charles adopted 
the name of his stepfather, Sajous. During his 
teens the family lived in Mexico and California. 
He matricualted at the Medical School of the 
University of California, transferred to Jefferson, 
and received the medical degree in 1878. His initial 
interest was in laryngology; he was appointed 
Clinical Lecnlrer at Jefferson (1883-1891) and in 
r898 published Lectures on the Diseases of the Nose 
and Throat: Delivered During the Spring Session of 
] effirson Medical College, a work dedicated to 
Samuel D. Gross, M.D. 
In 1892 Sajous abandoned his practice and 
teaching positions for the study of internal 
secretions with Brown-Sequard in France. 
Following his return to Philadelphia in 1897, 
Sajous became Professor of Laryngology and Dean 
of the Faculty of the Medico-Chirurgical College. 
From 1910 to 1922 he was Professor of Applied 
Therapeutics at Temple University Medical College 
and, from 1921 until his death in 1929, Professor 
of Applied Therapeutics at the Graduate School 
of the University of Pennsylvania. When 
his physician son, Louis Theodore, also an 
endocrinologist, died three months before the 
father, it was the termination of the 900-year-old 
name of the Medici of Florentine history. 
Dr. Sajous published the first American 
textbook of endocrinology in 1903, The Internal 
Secretions and the Principles ofMedicine (in two 
volumes of 1,873 pages). He held office and 
membership in many medical and other activities, 
including the American Medical Editors' 
Association (President, 1903), American 
Association for the Study of Internal Secretions 
(President, 1917), and American Therapeutic 
Society (President, 1919). He also authored the 
Annual of the Universal Medical Sciences (1888­
1896), and the SaJous Analytic Cyclopaedia of 
Practical Medicine (60 volumes). 
Dr. Sajous had a running battle with the 
physiologists and tllose who used the physiologic 
approach to the study of internal secretions. He 
believed that animal experimentation led to 
therapeutic incompetence. His major contributions 
were broad concepts and appreciation of the 
importance of internal secretions in health and 
disease. His specific observations were of lesser 
importance. 
Spanning tlle decades at the turn of the century, 
Dr. Francis X. Dercum (Figure 17-2) (Clinical 
Professor of Nervous and Mental Diseases at 
FIG. l7-r. Charles Eucharist de Medici Sajous, M.D., early 
investigator of internal secretions. 
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Jefferson from 1883 to 1900 and Chairman of the 
Department from 1900 to 1925) had dual interests 
in neuropsychiatry and endocrinology. He was 
the author of the Biology of Internal Secretion 
(192+) and wrote many articles in the field of 
endocrinology. In 1892 he described adiposa 
dolorosa (Dercum's disease), which is probably 
not of endocrine or metabolic origin. Dr. Milton 
K. Meyers (neuropsychiatrist at Jefferson, 1939­
195+) published in 1915 the first American edition 
and English translation from the German of 
Wilhelm Falta's textbook, The Ductless Glandular 
Diseases (673 pages). Samuel A. Loewenberg 
(Figure 17-3), Clinical Professor of Medicine at 
Jefferson, published Clinical Endocrinology-the 
first edition in 1937 and the second in 19+1. 
The relationship of the endocrine glands to 
disease states was noted by the clinicians of the 
nineteenth century: the adrenal by Addison 
(insufficiency), and the thyroid by Graves 
(thyrotoxicosis) and Basedow (myxedema). An 
understanding of the mechanisms responsible 
for these diseases awaited developments in 
biochemistry through which the hormones could 
be identified, purified, measured in body fluids, 
and satisfactory products made for pharmacologic 
and therapeutic experimentation. This era began in 
the twentieth century and matured from 1950. 
David W. IZramer, M.D. 
Following the report in 1889 by von Mering and 
Minkowski that diabetes mellitus followed 
pancreatectomy, a search for the hypoglycemic 
hormone of the pancreas began. In a talk before 
Jefferson's Alpha Omega Alpha Society around 
1952, Dr. Charles H. Best (codiscoverer of 
FIG. 17-2. Francis X. Dercum, M.D., studied the biology FIG. 17-3. Samuel A. Loewenberg, M.D., author of Climcal 
of internal secretions. Endocnnology. 
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insulin with Dr. Frederick G. Banting in J922) 
acknowledged that Dr. David W. Kramer (Figure 
17-4) (Jefferson, 1912) had demonstrated the 
effectiveness of a pancreatic extract in humans .. 
The marked toxicity of the product preclud~d Its 
use, and the study was terminated. In 1922, Just 
before the announcement of the discovery of 
insulin, Kran1er5 published a paper on Clinical. 
Observations on the Pathogenesis of Diabetes Mellttus. 
His interest and work was thus of preliminary 
aid to Banting and Best in their isolation of 
a clinically useful product (insulin). Kramer 
maintained a lifelong interest in the treatment of 
diabetes which, ., because of its vascular effects, 
motivated his study of peripheral vascular chseases. 
In this field he became a national authority, with 
publication of Manual oj Peripheral Vascular . 
Disorders in 1940 and Peripheral Vascular DtSeases 111 
1948. The Bertha and David Kramer Professorship 
of Medicine was created in 1974 and first held 
by Dr. Joseph Glennon as Director of the 
Division of Endocrine and Metabohc DIseases 
111 1977. 
Garfield G. Duncan, M.D., and 
Insulin 
Shortly after the availability of insulin, a young 
Canadian physician, Dr. Garfiel~ G. Dunc~n . 
(Figure 17-5), joined the faculty 111 19~7, bnng111g 
with him skills in the treatment of dIabetes 
mellitus acquired during the early years of d1e . 
availabilitv of insulin for human use. Dunng hiS 
30 years ~n the faculty Dr. Duncan made many 
important observations, not o~ly about diabetes 
mellitus but also other endocnne and metabohc 
disorders. His many publications were important 
in establishing the nature, and especially d1e 
FIG. [7-4-. David W. Kramer, M.D., pioneer investigaror of FIG. 17-5. Garfield G. Duncan, M.D., author of Diseases of 
diabetes mellirus and insulin therapy. Metabolism. 
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treatment, of the "whole" patient. Duncan's 
textbook, Diseases ofMetabolism (1942 and I947), 
was the standard text used by students and 
practitioners. He was more than a diabetologist. 
As a well-rounded clinician, his lectures, 
conferences, and rounds at Pennsylvania Hospital, 
where he was Chief of Medicine, were 
informative, well-prepared, and delivered with a 
nasal twang. Students were frightened by him; he 
gave the impression that he lacked a sense of 
humor. They knew he would not tolerate 
incompetence or improper bedside manner. 
Nevertheless, students appreciated him and learned 
from watching and being supervised by a 
dedicated teacher and clinician. Duncan elected to 
join the faculty of the University of Pennsylvania 
when it affiliated with Pennsylvania Hospital 
in 1957. He died in I983 at the age of 81. Dr. 
Theodore G. Duncan (Jefferson, I955) succeeded 
his father as Chief of Diabetes at Pennsylvania 
Hospital and was one of a few select physicians 
picked to evaluate the clinical usefulness of human 
insulin. 
Abraham Cantarow, M.D. 
After graduation from Jefferson in [924, Abraham 
Cantarow (Figure 17-6) joined its faculty in clinical 
chemistry. It was said that he selected Jefferson as 
his medical school because most of the textbooks 
were written by Jefferson faculty (Hawk and 
Bergeim's Chemistry, Brubaker's Physiology, 
DaCosta's SUt;!je1'y, McCrae's editions of OsIers 
Principles and Practice ofMedicine, and Schaeffer's 
Morris) Anatomy). For the rest of his academic 
career he devoted his life to his alma mater as a 
teacher, researcher, and active member of the 
Alumni Association, of which he was President in 
[964. His interest m clinical chemistry directed 
him to the field of endocrinology and metabolism 
in particular. Dr. Cantarow was a complete 
clinician and an excellent bedside teacher who 
used pathophysiology as the basis for explaining 
disease mechanisms. His early appreciation of 
metabolic alterations in carcinogenesis steered him 
into cancer research. Despite the duties imposed 
when he accepted the Chairmanship of the 
Department of Biochemistry, he continued his 
research career while delivering an excellent course 
in basic science. Following his Emeritus retirement 
in 1966, Cantarow joined the staff of the National 
Cancer Institute, National Institutes of Health. 
• Early Advances 
The fourth decade of the twentieth century saw 
the blossoming of endocrinology. By 1940 
techniques were developed that permitted 
investigation of the function and malfunction of 
the endocrine system. Bioassay for estrogens, 
androgens, and gonadotropins, chemical assays for 
17-ketosteroids and pregnandiol, and staining 
methods for studying vaginal cytology were 
available for use in a clinical setting. About this 
time two men, Drs. Abraham E. Rakoff (Figure 
17-7), and Karl E. Paschkis (Figure 17-8), joined 
the faculty and with Dr. Cantarow were to play a 
major role in the field of endocrinology, not only 
at Jefferson but nationwide. 
FIG. I7-6. Abraham Cantarow, M.D.; Professor of 
Biochemistry, researcher in metabolism and endocrinology. 
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• The Paschkis Stimulus 
Drs. Karl and Margaret Paschkis, the latter a 
pediatrician, were born and educated in Vienna. 
Thev were very vocal activists in OpposItIon to the 
take~ver of Austria by Nazi Germany-they. . 
escaped with nothing. Following a short. penod 111 
England, the Paschkises came to the Umted States 
and settled in Philadelphia. After a year at the Fels 
Institute, Temple University, Dr. Karl Paschkis 
joined the Department of Physiology and, a httle 
later, the Department of Medicine. r::e was active 
in each Department for the rest of his hfe. . 
Dr. Paschkis was a trained intermst WIth an 1I1terest 
in endocrinology and thereby a fortuitous 
interactor for Dr. Abraham Rakoff (Jefferson, 1937) 
who, following internship at Fran~aord ~ospital, 
joined the Department of Obstetncs. WhJ!e an 
undergraduate at the University of Pennsylval1la, 
Dr. Rakoff did research in cytology and sta1l1111g 
techniques. He had a major interest in this 
area for the rest of his career, refin1l1g and 
developing new techniques for use in gynecologic 
endocrinolol:,'Y' Like Cantarow, Rakoff was 
devoted to Jefferson and served as President of the 
Alwnni Association in 1969-they both received 
the Alumni Achievement Award. 
In 194-0, Cantarow, Paschkis, and Rakoff joined 
to form an endocrine outpatient facility, an 
endocrine laboratory, and an informal research 
group. By 194-5 they became a recoWIized 
interdepartmental group that, by action of the 
Board of Trustees in 194-8, was formalIzed as the 
Division of Endocrine and Cancer Research. 
Representatives of the DeparU11ents of Surgery, 
Anatomy, Pathology, Physiology, Urology, _ 
Psychiatry, and Ophthalmology were members of 
the Division and were consulted 111 the plann111g 
FIG. P-7. Abraham E. Rakoff, M.D., gynecologic fIG. 17-8. Karl Paschkis, M.D., clinical and research 
endocnnologist. endocrinologist. 
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and implementation of basic and clinical research. 
They cooperated also in the monthly research 
conferences. In 194-8 John J. Schneider, M.D., 
Ph.D., and in 1951, Joseph J. Rupp (Jefferson, 
194-2; Figure 17-9), after a four-year period of 
residency and fellowship training at Jetlerson, were 
given appointments in the Department of 
Medicine and joined the Division on a fuJI-time 
basis. 
Dr. Schneider, a graduate of the University of 
Chicago School of Medicine, completed his 
postgraduate education in the field of steroid 
chemistry at the Graduate School of the Mayo 
Clinic. At Jefferson he continued his study of 
steroid metabolism for the next 30 years. He had 
only three research associates, and no more than 
one at a time. Patricia Horstmann, B.A., and 
Constance Decourcy, Ph.D., each stayed for a few 
years. Dr. Marvin L. Lewbart (Jefferson, 1957), 
after internship at Lankenau Hospital, completed 
his graduate work at the Graduate School of the 
Mayo Clinic and returned to Jefferson as Dr. 
Schneider's associate, an association that lasted 
until the latter's retirement in 1975. This was a 
most productive combination. The two not only 
collaborated but each carried out individual 
projects. It was a unique laboratory in which 
admission was limited and often by invitation 
only. There were neither technicians nor 
housekeeping personnel. Dr. Schneider cleaned the 
glassware, sCnJbbed the floors, and painted the 
laboratory. His day began about 5 A.M. and 
continued until 9 or 10 P.M., with an interruption 
for breakfast with Drs. Robert MandIe and 
Harry Smith, for coffee with Rupp, and for lunch 
and dinner in the hospital cafeteria. The only 
distraction in the laboratory was classical music. 
Dr. Schneider was an avid reader of history, 
especially military and political, an interest that 
continued into his retirement. 
Advanced Basic Research 
Dr. Schneider enjoyed a worldwide reputation in 
the field of steroid chemistry. His expertise in 
evaluating the effects of various tissue enzymes on 
the steroid nucleus led to the development of 
methods tor the isolation and identification of 
steroid metabolites including some not previously 
described. He was consulted by some for help in 
identification of a new compound and by others 
who needed a new compound to continue their 
endeavors. The individual and joint research of 
Schneider and Lewbart resulted in publication of 
more than 50 papers. 
The activities of the members of the Division 
of Endocrine and Cancer Research encompassed 
both the fields of general and reproductive 
endocrinology and carcinogenesis. Dr. Paschkis 
was interested in aU aspects of endocrinology, but 
to a lesser extent in reproductive endocrinology. 
Most of his papers were concerned with clinical 
and basic science aspects of the pituitary, thyroid, 
and adrenal glands. Dr. Rakoff, on the other 
hand, while well-versed in aJl areas, was mainly 
concerned with gynecologic endocrinology. He 
FIG. 17-9. Joseph J. Rupp, M. D., Director of the Division 
of Endocrine and Cancer Research, 1961. 
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was joined by Dr. Alvin F. Goldfarb who made 
contributions not only in patient care and teaching 
but also in clinical research. Dr. Rakoff and his 
associates developed procedures for increasing the 
sensitivity of the pregnancy test, for the bioassay 
of pituitary and chorionic gonadotropins, and for 
assessment of the pituitary-ovarian-adrenal 
function in infertility and hirsutism. Dr. Rakoff's 
clinical reputation was worldwide and his patients 
came from afar, especially infertile couples and 
hirsute women. Dr. Rupp, who became Chief 
of the Diabetes Section, studied various aspects 
of thyroid function in both humans and lower 
animals. His was the first report of "T-3 Toxicosis." 
The joint studies of Paschkis and Cantarow in 
the field of cancer research resulted in several 
important observations on the influence of tumor 
growth on the endocrine system, of the effects of 
hormones on tumor growth, and the intermediary 
metabolism of tumors. There were two 
pathologists associated with them, initially Dr. 
Joseph Stasney and later Dr. James W. Goddard. 
The studies of humoral factors in carcinogenesis 
and pyrimidine metabolism in malignant and 
normal growth indicated that malignant tissue 
utilized signficantly greater amounts of uracil than 
did normal tissue. This observation was important 
to the development of the antimetabolite, 
5-flurouracil. More than 250 papers were published 
by members of the Division. 
Endocrine and metabolic research at Jefferson 
was not limited to the active members of the 
Division. Dr. Savino A. D'Angelo (Department of 
Anatomy) made significant contributions to an 
understanding of hypothalanlic-pinlitary thyroidal 
function in pregnancy and other conditions. Dr. 
Franz X. Hausberger (Department of Anatomy) 
studied fat metabolism in normal and diabetic 
states. Drs. Irwin Jack Pincus (Jefferson, 1937; 
Deparunent of Physiology) and W. Paul Havens, 
Jr., (Deparunent of Medicine) reported on the 
influence of impaired liver function on hormonal 
function. Dr. Domcnic A. DeBias (Department of 
Physiology) was actively engaged in endocrine 
research during his time at Jefferson. Dr. William 
B. Pearlman (Deparunent of Biochemistry) made 
major contributions in the field of sex steroid 
metabolism. 
Education and Patient Care 
Clinical and basic research were important, but 
not the dominant role of most members of the 
Division in the overall functions of the medical 
school. Drs. Paschkis and Rakoff, by example and 
fiat, insisted that patient care and dle education of 
undergraduate and graduate students have first 
priority. These clinical activities were important 
because they permitted a hands-on approach to 
inpatient and outpatient care. Each clinic session 
was followed by a conference where the unusual 
problems were discussed. Students and residents 
were given the opportunity to present and discuss 
problems of their individual interest. 
Members of the Division participated in 
undergraduate, graduate, and continuing medical 
education. Dr. Paschkis gave the lectures in 
physiology. Dr. Rakoff was responsible for 
gynecologic endocrinology, and Dr. Rupp 
participated in teaching of the second year. Before 
the introduction of the new curriculum in 
the mid-I960s, undergraduate education in 
endocrinology was reinforced over dle four-year 
period. The facilities of the Division were available 
to students; they came with their interests and 
volunteered to be summer research associates. 
Students enjoyed their exposure to endocrinology, 
and the faculty mutually delighted in the students, 
whom they considered to be the school's most 
important asset. Members of the Division were 
honored by the students. Three (Cantarow, 
Rakoff, and Rupp) had class portraits painted. 
Those three, as well as Dr. Paschkis, had 
yearbooks dedicated to them, and some were 
selected for the Lindback Award for outstanding 
teaching. 
Graduate education of residents and fellows 
began shortly after the Division was established in 
1940 and expanded after World War II. The 
Division was awarded a National Institutes of 
Health training grant. In addition to An1ericans, 
trainees came from Canada, Mexico, South 
American, Europe, and the Near and Far East. 
Most remained for one year and some for two or 
more. The Residents and Clinical Fellows were 
responsible for patient care. They also prepared 
clinical and teaching conferences under the 
supervision of the faculty, including Sidney M. 
Wolfe (Jefferson, 1947), Jack Zagerman, Rachmel 
Cherner (Jefferson, 1955), and Sheldon Gilgore 
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(Jefferson, 1956). Dr. Gilgore, who studied 
carbohydrate metabolism, reported the definitive 
study on the hypoglycemic effects of aspirin. 
He subsequently became President of Pfizer 
Pharmaceuticals, an Alumni member of Jefferson's 
Board of Tmstees, and Chairman of the Board at 
Clark University. 
Among the other trainees were Dr. Angelo 
DiGeorge, who became Chief of Endocrinology at 
St. Christopher's Hospital for Children; Dr. 
William A. Abelove (Jefferson, 1951), who accepted 
a position in the diabetic section at the University 
of Miami; and Dr. Agustin M. DeAndino 
(Jefferson, [944), who returned to Puerto Rico 
where he practiced endocrinology until his 
untimely death. Dr. Doris Bartuska returned to 
the Medical College of Pennsylvania in the fields 
of both endocrinology and medical education. 
Dr. Ruth Ann Fitzpatrick became Chief of 
Endocrinology at the Crozer-Chester Hospital. 
Dr. John Aloi accepted a position at Stony Brook 
Medical School (SUNY) and became Professor of 
Medicine and Chief of Endocrinology. Dr. Joseph 
T. Curti (Jefferson, [963), following his training, 
entered the pharmaceutical industry and became 
Vice-President of Roerig Company. Dr. Francis 
H. Sterling (Jefferson, 1960) returned to the 
Veterans Hospital and the University of 
Pennsylvania. He received many awards as an 
outstanding teacher. Other Jefferson graduates 
who were Fellows in endocrinology included Drs. 
Stephen L. DeFelice (1961) and Murray B. Grosky 
(1961). Later members of the Division were Drs. 
Joseph S. Fisher (Jefferson, 1970) and Edward B. 
Ruby (Jefferson, 1971). 
• Further Graduate Teaching 
Dr. Ralph A. Carabasi, Jr. (Jefferson, 1946) 
completed his training in endocrinology and 
oncology at Tulane and was appointed in the 
Department of Medicine in 1950. He aided in the 
student and resident training programs and was 
especially active in the Diabetic Clinic. 
Dr. Stanley N. Cohen, a graduate of the 
Medical College of Virginia (1952), served as Chief 
Pathologist and Head of the Clinical Laboratories 
at Fort Gordon, Georgia (1954-1956). He took a 
medical residency at the Veterans Administration 
Hospital in Richmond, Virginia (1956-1958) and 
became a National Institutes of Health Fellow in 
endocrine and metabolic diseases at the University 
of Pennsylvania (1958-1959). After joining the 
Jefferson faculty in the Department of Medicine in 
1959, Cohen's special interest and training in 
diabetes mellitus led to his holding all the major 
positions in the local affiliate of the American 
Diabetes Association (President, 1978-1980; 
Chairman of the Board, [980-[98[; and President 
of the Professional Section, 198[-1983). He was a 
cofounder at Jefferson of the Sexual Function 
Center, as the outgrowth of a National Institutes 
of Health grant for the research into the problem 
of impotence in diabetes mellitus (1977-[980). This 
multidisciplinary center for the diagnosis and 
treatment of impotence in males became one of 
the largest of its type in the world. In 1985 he 
cofounded, with Dr. Steven R. Peikin, the 
Jefferson Nutrition Program. 
Graduate training was not limited to those who 
could spend a year or more in the program. 
Residents at Jefferson and also the affiliated 
hospitals, especially the Naval Hospital, often 
elected to experience three to six months at 
Jefferson. The program was not limited to those 
concerned only with clinical training. Three 
candidates for the Ph.D. degree in physiology 
fulfilled part of the course requirements in the 
Division. Dr. Domenic DiBias, after receiving his 
degree, joined the faculty in the Physiology 
Department. He later accepted an appointment at 
the Philadelphia College of Osteopathic Medicine 
as Professor and Head of the Departments of 
Physiology and Pharmacology and became 
Assistant Dean. Dr. Frederick D. DeMartinis 
joined the staff of the Medical College of 
Pennsylvania and became Professor of Physiology. 
The late Arthur Segal, D.V.M., was Professor of 
Physiology at the School of Veterinary Medicine 
of the University of Pennsylvania. 
In addition to conferences held on campus, Dr. 
Paschkis had "beer-and-pretzeI" meetings at his 
home, attended by faculty, trainees, and students. 
Here dle discussions began with endocrinology 
but usually more time was spent discussing 
history, politics, and music. A highlight for 
members of the Division was carol singing at the 
Paschkis home on the third Sunday of Advent. 
Dr. Rakoff had an active training program in 
gynecologic endocrinology. Dr. Alvin F. Goldfarb, 
one of his Fellows, joined him in carrying out the 
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research, education, and clinical activities of 
residents and trainees in the Department of 
Obstetrics and Gynecology. He accepted an 
appointment at Pennsylvania Hospital and became 
active in their endocrine division. 
In 1961 Drs. Rupp, Rakoff, and Goldfarb 
initiated programs in continuing medical education 
when they presented a J3-week night course in 
endocrinology for the practicing physician. This 
course was given for several years and was 
replaced by a day course. Members of the Division 
participated in continuing medical education 
courses presented by other Departments and 
Divisions at Jefferson and its affiliated hospitals. 
These included three yearly Seven Springs 
Symposia at the Latrobe Hospital area and yearly 
ongoing Eastern Shore Medical Symposia with the 
University of Delaware. 
Division Organization 
Following the death of Dr. Paschkis in 1961, Dr. 
Rupp was appointed Director of the Division, a 
position he held until he was made Assistant 
Director of Continuing Medical Education in 
1969. He was replaced by Dr. Richard A. Field, 
internationally known in the special area of 
diabetic retinopathy. The latter was responsible for 
bringing Dr. Nicholas Zervas to Jefferson for the 
transsphenoidal method of pituitary ablation for 
the treatment of diabetic retinopathy. Dr. Field 
returned to Boston in 1971. After a hiatus, Dr. 
Sheldon R. Schlaff became the interim Director 
from 1974- to [977· 
In 1977 Dr. Joseph A. Glennon (Figure 17-10) 
was appointed the first Kramer Professor of 
Medicine and Chief of the Division of 
Endocrinology and Metabolic Diseases. He 
received his M.D. degree from the State 
University of New York (Downstate, 1957); 
interned at St. Vincent's Hospital in New York 
([958); and took his residency in internal medicine 
at St. Vincent's Hospital (1959) and Hartford 
Hospital ([961-1963), interrupted by United States 
Navy duty (1959-1901). He taught in the 
Department of Medicinc at the University of 
Wisconsin (1965-[971), Tufts University (1971­
1973), and as Professor at Texas Tech University 
School of Medicine, Lubbock, Texas (1973--1977). 
He became certified by the American Board of 
Internal Medicine in 1964-, was recertified in 1974-, 
and board certified in Endocrinology and 
Metabolism in 1972. 
Before coming to Philadelphia, Dr. Glennon 
had much clinical experience as attending 
physician and consultant in civilian and Veteran's 
Administration Hospitals in Wisconsin, 
Massachusetts, and Texas. He was active in the 
pertinent professional societies of his specialty and 
served in the curriculum planning of several 
medical schools. 
Dr. Glennon's main research interest has been in 
the fields of diabetes mellitus and obesity. His 
FIG. 17-10- Joseph A. Glennon, M.D.; Director of the 
Division of Endocrine and Metabolic Diseases (1977-). 
Firsr Kramer Professor of Medicine. 
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studies involved also the nervous system, the liver, 
enzyme systems, the lungs (especially sarcoidosis), 
and the inevitable path of endocrine changes in 
carcinoma. In conjunction with Drs. Boas Gonen 
and Steven Nagelberg at Jefferson, research 
continued in the area of hyperlipoproteinemia and 
gonadotrophins. 
While the Division remains a distinct entity 
within the Department of Medicine, its history 
is strongly one of interdepartmental cooperation 
in aU the basic sciences as well as the clinical arena 
of physical and mental health. There are 
approximately 5,000,000 diabetics in the United 
States and possibly an equal number not yet 
diagnosed. Even the meticulous control of 
the blood sugar level with insulin does not 
prevent the vascular, neurological, renal, and 
ophthalmologic complications in many patients. 
The full understanding of obesity and its control 
remains open for further investigation. Continued 
interaction by new faculty and the added 
dimension of an Institute of Molecular Medicine 
provide the path for Jefferson's future distinction 
in the field of Endocrinology and Metabolism. 
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